Topic
Cancer Genomics
Latest pieces
- Tempus acquires Personalis in $1.5bn deal, deepening push into cancer genomics
27 Sept 2026
- Merck secures first approval for an oral PCSK9 inhibitor, reshaping the cholesterol market
27 Sept 2026
- Spire Healthcare appoints advisers as private hospital consolidation accelerates
26 Sept 2026
- Optum closes $3.2bn Landmark acquisition, extending home-based care reach
24 Sept 2026
- NHS 18-week compliance reaches 60.4% as elective recovery slows
23 Sept 2026
- Japan opens reimbursement pathway for digital therapeutics
20 Sept 2026
- MKTG Holdings Acquires Global Health Data Analytics Firm for $1.2bn, Eyeing Emerging Markets
6 Sept 2026
- Syngene International Acquires Novartis's UK Research Hub in £280m Deal, Bolstering Global R&D Footprint
2 Sept 2026
- AstraZeneca Advances Oral Obesity Drug into Phase 3, Signalling Intensified Competition
27 Aug 2026